News
-
-
-
-
COMMUNIQUÉ DE PRESSE
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
CureVac to present first CVGBM Glioblastoma cancer vaccine clinical data at ESMO 2024 Congress. First-in-human study results to be shared, highlighting mRNA technology's potential for cancer vaccines -
-
-
-
-
COMMUNIQUÉ DE PRESSE
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
CureVac announces Q2 2024 financial results, new agreement with GSK, strategic workforce reduction, milestone payment, board appointments, CFO transition, and cash position update -